Transgenic K18-hACE2 were immunized (1 μg of Spikevax, Moderna) once and had detectable titers of neutralizing antibodies to the index virus SARS-CoV-2D614G 1 week prior to infection compared to the control groups (Fig. 4a; Supplementary Fig. 10a). This evidence concerns the gene KRT18 and infection.